Green Tea for Health & Longevity - Quick Reference Sheet

Green Tea for Health & Longevity

Created on 10/01/2026 – Quick Reference based on Evidence Review created using AI4L / Opus 5.5 – Audit

Green tea, the lightly processed leaf of the tea plant taken as a brewed beverage, powder or concentrated extract supplements, is used as a health and longevity habit. It produces small drops in cholesterol and blood pressure, mainly with extracts, and Asian population studies tie regular drinking to longer life. Brewed tea offers modest, low-risk potential benefits; high-dose extracts, especially taken on an empty stomach, can injure the liver. (Full Review)

Protocol

Brewed-tea protocol (traditional, epidemiology-based)
3–5 cups daily
About 700–1,200 mL; 2–3 g leaf per 240 mL water at 70–80 °C for 2–3 minutes
Standardized extract approach
300–800 mg EGCG daily with food
Typical trial doses; split into two doses with meals to reduce peak exposure and nausea
Time of day
Morning to early afternoon
For caffeinated forms; decaffeinated or low-caffeine tea later; extracts with breakfast or lunch
Time to effect
Lower mortality
Years to decades
Mortality associations reflect habitual intake
LDL & blood pressure
4–12 weeks
Changes appear in trials
Alertness
Within an hour
Alertness and attention sharpen for about two hours after intake

Benefits

Contraindications
  • Concentrated extracts: active liver disease, ALT above 2 times the upper reference limit, cirrhosis (Child-Pugh Class B or C), or prior herbal liver injury
  • Concentrated extracts: known HLA-B*35:01 carriers
  • Pregnant or breastfeeding women: extracts entirely; total caffeine above 200 mg/day
  • Children and adolescents under 18: concentrated extracts
  • Iron-deficiency anemia (ferritin below 30 ng/mL): tea with meals
  • Caffeinated forms: uncontrolled arrhythmia, panic disorder, or severe insomnia
  • Nadolol or celiprolol (beta-blockers); bortezomib (myeloma drug)
  • Extracts stacked with liver-toxic botanicals (Garcinia cambogia, kava, high-dose niacin, ashwagandha)
  • Very hot drinking with alcohol or smoking
Key Interactions
  • Lisinopril (ACE inhibitor)
  • Statins (atorvastatin, rosuvastatin, simvastatin)
  • Raloxifene (osteoporosis drug)
  • Warfarin, tacrolimus and sildenafil
  • CYP1A2 inhibitors (fluvoxamine, ciprofloxacin) and stimulant medications (amphetamine, methylphenidate)
  • Liver-toxic drugs (methotrexate, isoniazid, ketoconazole): with extracts
  • Fexofenadine (antihistamine)
  • Acetaminophen (paracetamol) at high doses: with extracts
  • Caffeine-containing pain relievers and alertness aids (Excedrin Migraine, NoDoz)
  • Iron tablets; folic acid
  • Stimulant botanicals (guarana, yerba mate, bitter orange)
  • Additive cholesterol and blood-pressure agents (red yeast rice, berberine, plant sterols, beetroot nitrate)
  • Fasting protocols: with extracts

Risk & Side Effects

  • High: Liver injury from concentrated extracts
  • Medium: Caffeine-related sleep disruption and restlessness; nausea and digestive upset with extracts; esophageal cancer with very hot tea
  • Low: Reduced non-heme iron absorption; excess fluoride with very high intake; pregnancy: folate and caffeine concerns
  • Speculative: Thyroid suppression at very high catechin doses; pro-oxidant gut toxicity at megadoses

Monitoring

Marker Target Why
ALT 10–25 U/L Detects extract liver injury
AST 10–25 U/L Confirms liver pattern
GGT 10–25 U/L Sensitive liver marker
Ferritin 50–150 ng/mL Iron-absorption effect
Hemoglobin 13.5–15.5 g/dL (men); 12.5–14.5 g/dL (women) Detects anemia
LDL cholesterol Below 100 mg/dL Tracks lipid benefit
ApoB Below 80 mg/dL Atherogenic particle count
Blood pressure Below 120/80 mmHg Tracks vascular benefit
Fasting glucose 75–90 mg/dL Glycemic effect
HbA1c Below 5.4% Longer-term glycemia
hs-CRP Below 1.0 mg/L Inflammation trend
TSH 1.0–2.5 mIU/L Thyroid effect at high doses
Serum folate Above 15 ng/mL Folate absorption
HLA-B*35:01 Not carried Extract liver-injury risk

Cadence: Baseline before extracts or heavy daily intake; for extract users, liver enzymes at 1, 3 and 6 months, then every 6–12 months; lipids, ApoB, blood pressure and ferritin at 3 months, then every 6–12 months. Brewed-tea drinkers without risk factors follow routine annual labs.

Qualitative Assessment

  • Sleep quality and time to fall asleep, particularly after afternoon tea
  • Daytime alertness and focus without restlessness or palpitations
  • Digestive comfort after extracts, including absence of nausea
  • Energy levels and mood stability across the day
  • Absence of liver warning signs such as dark urine, yellowing of the eyes or unusual fatigue